Skip to content
ppharmaranks
Menu
Class IOngoing

Morphine Sulfate Injection recall

FDA recall D-0788-2026 · initiated Aug 4, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Aug 26, 2026How we research

Fresenius Kabi USA, LLC recalled Morphine Sulfate Injection in Aug 2026 — an FDA Class I recall (D-0788-2026) because Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #: 6402820, Exp. Date 12/2028

Quantity recalled: 625500 syringes

Details

Product
Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or Intravenous use, Rx only, Fresenius Kabi, Lake Zurich, IL. Unit of Use NDC Number 76045-004-01; Unit of Sale NDC Number 76045-004-11
Recalling company
Fresenius Kabi USA LLC
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide within the USA.
Initiated
Aug 4, 2026
FDA report date
Aug 26, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Morphine Sulfate Injection recalled?
Fresenius Kabi USA, LLC recalled Morphine Sulfate Injection in Aug 2026 — an FDA Class I recall (D-0788-2026) because Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL. Most serious — a reasonable probability that use will cause serious harm or death.
Why was Morphine Sulfate Injection recalled?
Per the FDA enforcement record, the reason for recall D-0788-2026 was: Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
Is a recalled Morphine Sulfate Injection dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Morphine Sulfate Injection are affected?
Distributed: Nationwide within the USA.. The recall covers these lots — Lot #: 6402820, Exp. Date 12/2028. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0788-2026.

Source: openFDA Drug Enforcement record D-0788-2026 ↗

← All drug recalls